Literature DB >> 21496864

Primary pulmonary chondrosarcomas: a clinicopathologic study of 4 cases.

Neda Kalhor1, Saul Suster, Cesar A Moran.   

Abstract

Malignant cartilaginous tumors of the lung are unusual, and although their occurrence has been reported in the literature in some cases, their separation from other benign cartilaginous tumors of the lung can be very difficult. Four cases of primary chondrosarcomas of the lung are presented. The patients are 2 men and 2 women between the ages of 51 and 69 years. Clinically, the most common symptoms were chest pain, dyspnea, and cough. Two tumors were centrally located, whereas 2 tumors were peripheral. Complete surgical resection was accomplished in all the patients. Histologically, 2 tumors were low grade of the hyaline type, whereas 2 tumors were predominantly myxoid chondrosarcomas. In the 2 myxoid chondrosarcomas immunohistochemical studies for keratin, desmin, smooth muscle actin, and CD31 were negative, whereas S-100 protein shows focal positive staining in both cases. Follow-up showed that one patient with low-grade tumor was alive and well at 36 months, whereas one patient with myxoid chondrosarcoma died 45 days after diagnosis because of surgical complications. Two additional patients were lost to follow-up. Our study highlights the ubiquitous distribution of chondrosarcomas and the histopathologic spectrum that these tumors may show when occurring in the lung.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21496864     DOI: 10.1016/j.humpath.2011.01.009

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Primary pulmonary chondrosarcoma and a fast-growing mass that accidentally mimicked teratoma.

Authors:  Jingjin Jiang; Qian Shen; Wei Ding; Jianying Zhou
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Primary chondrosarcoma presenting as an intrathoracic mass: A report of three cases.

Authors:  Xue-Yuan Wang; Su Hu; Ling-Chuan Guo; Jie Chen; Mo Zhu; Fei-Rong Yao; Chun-Hong Hu
Journal:  Oncol Lett       Date:  2014-06-23       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.